| Stage | CHRW | % of rev | EXPD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.4B | 100.00% | $4.1B | 100.00% | CHRW ×1.30 |
| Gross profit | $448M | 8.36% | $625M | 15.23% | EXPD +6.9pp |
| Operating income | $272M | 5.07% | $445M | 10.84% | EXPD +5.8pp |
| Pre-tax income | $250M | 4.67% | $448M | 10.91% | EXPD +6.2pp |
| Net income | $198M | 3.70% | $345M | 8.39% | EXPD +4.7pp |
| Stage | CHRW | EXPD | Gap · A − B |
|---|---|---|---|
| Revenue | $5.4B100.00% | $4.1B100.00% | CHRW ×1.30 |
| Gross profit | 8.36%$448M | 15.23%$625M | EXPD +6.9pp |
| Operating income | 5.07%$272M | 10.84%$445M | EXPD +5.8pp |
| Pre-tax income | 4.67%$250M | 10.91%$448M | EXPD +6.2pp |
| Net income |
| 3.70%$198M |
| 8.39%$345M |
| EXPD +4.7pp |
No disclosed counterparties: CHRW, EXPD.